Pharmaceutical company Baxter has issued a recall on four lots of intravenous (IV) solutions that were distributed to hospitals nationwide due to leaking containers and the presence of particles floating in the solutions. This is the second recall in weeks, and one of about a half dozen since last year.
Leaking containers could contaminate the medications and, if injected into patients, could lead to a bloodstream infection, worsened patient condition, or other serious adverse health consequences. Injecting a product containing particulate matter without in-line filtration may block blood vessels, which could lead to stroke, heart attack, damage to other organs including the kidneys or liver, or death.
The recall involves 0.9% sodium chloride injection, a saline solution for flushing IV lines and electrolyte balance; metronidazole injection, an antibiotic used to treat various infections; and Clinimix E 5/15 (5% AA w/Electrolytes in 15% Dextrose w Calcium) for fluid replenishment and caloric supply.
Baxter was made aware of the issue after two customers complained of leaking containers and three complained of particulate floating in the IV solutions. The drug company has informed its hospital customers of this recall. Any patients who experience problems that may be related to this recall should contact their doctor. Side effects should be reported to the Food and Drug Administration (FDA) Adverse Event Reporting Program at www.FDA.gov/MedWatch/Report.htm.
Two weeks ago, Baxter recalled two lots of IV solutions after customers reported seeing insects floating in the solutions. During 2015, the company issued five separate recalls on IV solutions due to mislabeling, container leakages, and the presence of particulate matter in the solutions.